Join
Live feed
·
PRReleasevia Quantisnow
Entero Therapeutics Inc. logo

Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings

ByQuantisnow·Wall Street's wire, on your screen.
ENTO· Entero Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTO (Entero Therapeutics Inc.) and more on Quantisnow.